Kane Biotech Inc.
$75,000.00 CAD
≈ 12 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2024-2025
- Agreement period
- September 2, 2024 – February 21, 2025
- Reference
- nrc-cnrc:172-2024-2025-Q2-1022709
Published purpose
As part of Multinational Corporate Collaboration Program, the project “DispersinB Wound Gel Development and Commercialization” will focus on scaling up the manufacturing process for DispersinB Wound Gel and ensuring the product meets specifications. The DispersinB Wound Gel is a combination product (device, drug, biologic) that is first of its kind in wound care as it disperses biofilms enzymatically.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions